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Hyperlipidemia is a major risk factor for coronary heart diseases 
and ischemia that leading to high rates of mortalities. 
Conventionally, hyperlipidemia is managed using agents that 
facilitate the clearance of total cholesterol (TC), triacylglycerides 
(TAG) and low density lipoprotein (LDL) from the body. Despite 
the use of these drugs, the disease still remained a global burden 
that affects the quality of life. The current study was done to 
investigate hypolipidemic properties of the methanolic extract of 
Boswellia dalzielli hutch (MEBDH) stem bark in rodents. The 
phytochemicals of the MEBDH were screened and determined 
qualitatively before performing acute toxicity study to determine 
the LD50 of the extract. Twenty five male albino rats 2-3 months 
old (150-210) g were distributed randomly into five groups [Group 
1: normal control received 200 μL normal saline daily for 3 weeks, 
Group 2: hyperlipidemic control induced by a single dose of Triton 
X-100 (150 mg/kg body weight) subcutaneously, followed by oral 
administration of 200 μL normal saline daily for 3 weeks. Group 2 
and 4: hyperlipidemic rats treated orally with MEBDH (200 and 
400 mg/kg body weight) respectively for 21 days. Group 5: 
hyperlipidemic rats treated with Simvastatin (5 mg/kg body 
weight) daily throughout the experimental period as positive 
control]. Administration of the extract did not cause any mortality 
regardless of the dose. However, the extract caused significant 
(p<0.05) decrease in TC, TAG and LDL-cholesterol levels in the 
treated rats. The decrease observed is significantly lower than 
that of untreated rats. In contrast, the level of HDL increased 
significantly (p<0.05) after treating the rats with the MEBDH stem 
bark. The extract of MEBDH possessed hypolipidemic agents and 
could be the potential substitute hyperlipidemic agents with side 
effect. 
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Cholesterol, a class of lipid plays major role in the assembly of 
biological membranes, brain development in children and other 
fundamental biological functions in animals (Khera et al., 2011). 
Despite the integral role lipids play to sustain cellular functions, 
high amounts of lipid is catastrophic and leads to the medical 
condition known as hyperlipidemia which is a metabolic disorder 
characterized by increased concentrations of total cholesterol 
(TC), triacylglycerol (TAG), low density lipoprotein (LDL), very low 
density lipoprotein (VLDL) and low concentrations of high density 
lipoprotein (HDL) (Chapman et al., 2011). Hyperlipidemia may 
equally induce other abnormalities like oxidation of free fatty acid 
that leads to the formation of ketone bodies (Maruthappan and 
Shree, 2010; Mishra et al., 2011), insulin resistance and 
consequently diabetes (Tang et al., 2011; Bako et al., 2014). It is 
a major risk factor for coronary heart diseases and ischemia that 
leading to high rates of mortalities. Clinically, statin, one of the 
inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA) 
reductase and most effective class of serum LDL cholesterol 
lowering drugs is associated with persistent side effects that 
includes diarrhea, nausea, gastric irritation and hyperuricemia 
(Baigent et al., 2005).  The goal of this work is to look for 
alternative treatment methods from natural sources that can 
circumvent the undue side effects caused by the conventional 
drugs. 
Natural products from plants contain numerous phytochemicals 
that are therapeutically potent (Bulus et al., 2011; Abdul et al., 
2014). For instance, plants from the Boswella species have been 
used locally for the treatment of hyperlipidemia (Mishra and Allan, 
2010). Specifically, the extract of the leaves, bark and roots of 
Boswella serrate, cartarri and papirifera has been administered to 
hyperlipidemic patients (Ben‐Yehoshua et al., 2012). However, 
the extract of B. dalzielli hutch species is yet to be investigated for 
antihyperlipidemic activities even though it contains diverse 
phytochemicals that may be therapeutically useful.  
In the current study, we evaluated the ability of the methanolic 






























In Vivo Ameliorative Effect Of Methanolic Extract Of Boswellia Dalzielli 
Hutch (Mebdh) Stem Bark On Triton X-100 Induced Hyperlipidaemia 
 
triacylglycerides, low density lipoprotein and high density 
lipoprotein concentrations of triton-X 100 induced hyperlipedemic 
rats. 
In this study, we carried out various experiments to investigate the 
acute toxicity and antihyperlipidemic activities of methanolic 
extract  of B. dalzielli stem bark on Triton X-100 induced 
hyperlipidemia in rats which is considered one of  the most 
effective in vivo model for antihyperlipidemic properties evaluation 
(Sudha et al., 2011; Ja’afaru et al., 2016). 
 
MATERIALS AND METHODS 
 
Collection of plant materials  
Fresh stem bark of B. dalzielli hutch was purchased from a local 
market at Kawo, Kaduna, Nigeria and identified by a certified 
botanist at the Department of Biological Sciences, Ahmadu Bello 
University (ABU) Zaria. The stem bark was chopped into small 
pieces and shade dried for 3 weeks, grinded to fine particles and 
then subjected to extraction. 
 
Preparation of extract 
The methanolic extract of Boswella dalzielli hutch (MEBDH) stem 
bark was prepared according to the method described by Ja’afaru 
et al., (2016). Briefly, 300g of the powdered sample was soaked 
in 1.25 L of 95% methanol (analytical grade) at room temperature 
for 72 h and filtered successively using muslin cloth and Whatman 
filter (GE healthcare Pte Ltd, Singapore). The extract was 
evaporated to dryness in a rotary evaporator at 45oC and the 
residue was collected and stored at 4oC. 
 
Phytochemical analysis 
The MEBDH stem bark was screened for the presence of 
saponins, tannins, flavonoids, glucosides, terpenoids, steroids, 
boswellic acids and alkaloids according to reagent-based 
phytochemical analyses described by Evans (2009). 
 
Experimental animals and induction of hyperlipidemia 
Thirty male albino rats 2 to 3 months old (150 – 210 g) were 
purchased from the animal unit of Nigeria Institute for 
Trypanosomiasis and Onchocerciasis Research (NITR), Kaduna, 
Nigeria and used for the experiment. The rats were acclimatized 
in the animal house, Kaduna State University (KASU) according 
to the international guidelines for animal handling, and they were 
allowed free access to standard animal diet and water ad libitum 
throughout the experimental period. Hyperlipidemia was induced 
by single subcutaneous administration of Triton X-100 (150 mg/kg 
body weight) to overnight fasted rats. The rats with elevated 
serum lipid profile parameters three days post-induction were 
considered hyperlipidemic and used for the experiment. 
 
Acute toxicity study  
Short term toxic effect of the working extract was investigated by 
oral administration of the extract up to five times in multiple 
proportion (ranges from 250-4000 mg/kg body weight) to three 
rats in the acute toxicity treatment group at stipulated time 
interval. On the other hand, 3 rats in normal control groups 
received 200 μL normal saline solution (containing 9.0 g/L Sodium 
Chloride with an osmolarity of 308 mOsmol/L, and 154 mEq/L 
Sodium and Chloride at 4.5 to 7.0 pH range). The rats were kept 
under frequent observation for the period of 24 hours to monitor 
certain behavioral changes and abnormal signs including 
tediousness, sedation, ruffled hair, clumping together, itching, 
restlessness and dose dependent mortality as reported by 
Muhammad et al., (2011) and Udem et al., (2011). 
 
Experimental design  
The animals were divided into five groups that comprised five rats 
each. Group one was considered normal control and were 
administered normal saline only. Group two comprised 
hyperlipidemic rats administered normal saline. Groups three and 
four are the test groups (hyperlipidemic rats) treated with 200 
mg/kg and 400 mg/kg body weight respectively. Group five was 
regarded as standard and the rats were administered with the 
standard drug, Simvastatin, at a dose of 5 mg/kg body weight, 
and all the treatments were carried out orally. After daily treatment 
for 21 days, rats were fasted overnight and blood samples were 
collected through cardiac puncture prior to sacrifice upon cervical 
dislocation. The whole blood was centrifuged, the serum were 
collected in a separate falcon tubes and were stored at 4ºC for 
further biochemical analysis. 
 
Lipid profile assay 
Serum total cholesterol (TC) and triglycerides (TGR) were 
evaluated according to the method described by Hyman et al., 
(2000) and Bako et al., (2014) respectively. Meanwhile, low 
density lipoprotein (LDL) and high density lipoprotein (HDL) were 
estimated in line with the procedures outlined by Baskol et al., 
(2007).  
  
Statistical analysis: One way analysis of variance (ANOVA) 
was carried out on the extracted data using SPSS statistical 
software version 21 (IBM Inc.), followed by Student-Newman-
Keuls multiple comparison test. The result was expressed as 





Table 1 shows some of the major phytochemicals present in the 
stem bark of B. dalzielli. The phytochemicals include boswellic 
acid, saponins, tannins, flavonoids, alkaloids, terpenoids, steroids 
and cardiac glycosides. 
  
Acute Toxicity test 
The methanolic extract of the stem bark of B. dalziella was not 
lethal to the rats even at higher doses of about 4000 mg/kg body 
weight. No significant physical and behavioral changes after 
administration of the extract in any of the group were observed. 
 
Table 1: Summary of phytochemical constituent of MEBDH 
detected qualitatively 
 
(+) stands for presence, whereas (–) stands for absence 
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Lipid profile assay 
The serum lipid profile of the hyperlipidemic rats treated with 
MEBDH stem bark is shown in Table 2. The result shows that 
treatment of hyperlipedemic rats with MEBDH significantly 
decreased the concentrations of TC, TAG, LDL and VLDL in a 
dose dependent manner. Also, the decrease observed in the 
treated group is significantly higher (p<0.05) than that of the 
untreated group (control group) administered with normal saline. 
Similarly, the standard drug, Simvastatin, reversed hyperlipidemia 
in treated rats by decreasing the levels of TC, TAG, LDL and VDL 
and increased the level of HDL significantly (p<0.05) (Table 2). 
 
Table 2: Serum lipid profile of Triton X-100 induced 
hyperlipidemia after 21 days of oral administration of MEBDH 




Results are expressed as mean ± standard deviation (SD). 
Values with asterisk symbol differed significantly (p<0.050) with 
normal control (n-Control) in each column. Values bearing 
superscripts in each column are also significantly lower (p<0.05) 
than the control (hl-Control). MEBDH: methanolic extract of 
Boswellia dalzielli hutch; SVT: simvastatin (standard drug). 
 
DISCUSSION 
The use of natural products is the mainstay of traditional medicine 
practiced in many developing nations of the world (Atawodi et al., 
2011). Even though most naturally occurring secondary 
metabolites are therapeutically potent, the exact mechanism of 
action and toxic levels of many of them are yet to be ascertained. 
In the current study, we investigated the ameliorative effect of 
MEBDH stem bark on hyperlipidemia in rats and it was observed 
that MEBDH stem bark has anti-hyperlipidemic properties. 
Hyperlipidemia is a major risk factor that contributes to the 
development of cardiovascular diseases and is associated with 
diabetes, coronary heart disease and obesity amongst many 
others (Robinson et al., 2014). Clinically, hyperlipidemia is marred 
by increased and decreased concentrations of TC, TAG, LDL and 
HDL respectively (Mizuguchi et al., 2007). In our study, we 
observed that MEBDH significantly decreased the concentration 
of TC in hyperlipidemic rats in a dose dependent manner. This we 
presume may be due to the ability of the extract to stimulate the 
excretion of cholesterol. Several antihyperlipidemic drugs such as 
Fluvastatin, Simvastatin and Alirocumab are known to act in a 
similar manner. The MEBDH stem bark also caused decreased in 
the level of TAG and LDL in the treated rats which may have 
occurred via increased catabolism of TAG and LDL. The 
catabolism of LDL produces bile acids that is easily eliminated by 
the body (Pandey et al., 2005). This activity helps to regulate the 
level of LDL-cholesterol in the body. 
Conversely, hyperlipidemic rats treated with MEBDH showed 
increased levels of HDL-cholesterol. High HDL-cholesterol level is 
known to protect against coronary heart diseases (Warnholtz et 
al., 2001). It is for this reason that HDL-cholesterol is often 
referred to as ‘good cholesterol’. The ability of the MEBDH stem 
bark to stimulate the biosynthesis of HDL-cholesterol in 
hypolipidemic rats demonstrates the therapeutic potency of the 
extract. Although our phytochemical analysis shows the presence 
of tannins, cardiac glycosides and boswellic acids amongst 
others. We presume that these compounds synergistically 
reversed hyperlipidemia in the treated rats. 
 
Conclusion 
The present study is the first of its kind to demonstrate the 
hypolipidemic potentials of MEBDH stem bark in rats, which 
brings about significant reduction in chances of developing 
cardiovascular complications especially atherosclerosis. Though 
the exact mechanism of hypolipidemic action of the extract was 
not established, the possible beneficial effect of phytochemicals 
present in the extract can be taken into consideration as they are 
potent antioxidants and can prevent the oxidation of Low density 
lipoprotein cholesterol. The study also indicated that 
administration of MEBDH at high dose does not acutely affect 
the experimental animals in all respect, with LD50 greater than 
4000 mg/kg, revealing certain level of safety of the extract. 
However, acute toxicity examination does not guaranteed the 
safety of active principles under investigations until all the other 
criteria for toxicity study were fulfilled. Therefore, MEBDH stem 
bark showed hypolipidemic and cardio-protective properties in 
triton x-induced hyperlipidemic rats. The most active compounds 
of the extract need to be screened for potential use as a 
hypolipidemic agent. This study also corroborates previous 




MEBDH stem bark was found to possessed potential bioactive 
compounds that ameliorate anomalies in hyperlipidemic condition 
which are yet to be studied as individuals. Therefore, we 
recommend that the safety and hypolipidemic potential of 
phytochemicals especially boswellic acid extracted from B. 
dalzielli hutch should be further explored both in vivo and in vitro 
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